Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intact mass and peptide mapping approaches to characterize lipoprotein species of fHbp.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same author

A Phase III Clinical Trial of Immunogenicity and Safety of Meningococcal A and C Polysaccharide Conjugate Vaccine in Infants Aged 3-5 Months.

Vaccines·2025
Same author

Age-specific prevalence of serum bactericidal antibody against meningococcal serogroup Y in China.

The Journal of infection·2024
Same author

Influence of Dietary Salt Intake on T2D Treatment.

Frontiers in endocrinology·2022
Same author

Health-related quality of life of people with type 2 diabetes and its associated factors at a tertiary care clinic in Ningbo, China: A cross-sectional study.

Endocrinology, diabetes & metabolism·2022
Same author

MADE: A Computational Tool for Predicting Vaccine Effectiveness for the Influenza A(H3N2) Virus Adapted to Embryonated Eggs.

Vaccines·2022

Related Experiment Video

Updated: Nov 18, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.1K

Meningococcal vaccines in China.

Yinghua Xu1, Yanan Li1, Shanshan Wang1

  • 1Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.

Human Vaccines & Immunotherapeutics
|February 10, 2021
PubMed
Summary

Meningococcal meningitis vaccination significantly reduced disease incidence in China since the 1980s. Enhanced surveillance and development of serogroup B vaccines are crucial for improved control.

Keywords:
ChinaNeisseria meningitidisconjugate vaccinesinvasive meningococcal diseasepolysaccharides vaccinesquality control

More Related Videos

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
07:07

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice

Published on: June 27, 2020

5.6K
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.3K

Related Experiment Videos

Last Updated: Nov 18, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.1K
Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
07:07

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice

Published on: June 27, 2020

5.6K
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.3K

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Epidemiology

Background:

  • Meningococcal meningitis, caused by *Neisseria meningitidis*, was a significant public health concern in China.
  • The introduction of meningococcal vaccines in the 1980s led to a substantial decrease in disease incidence.
  • Current vaccine market in China includes polysaccharide, conjugate, and combined formulations, primarily domestically produced.

Purpose of the Study:

  • To highlight the impact of meningococcal vaccination on disease reduction in China.
  • To emphasize the need for enhanced national surveillance of meningococcal disease.
  • To advocate for further investment in the development of serogroup B meningococcal vaccines.

Main Methods:

  • Review of historical disease incidence data before and after vaccine introduction.
  • Analysis of the current vaccine landscape in China.
  • Assessment of the need for improved surveillance and vaccine development.

Main Results:

  • Meningococcal vaccination has markedly reduced the incidence of meningococcal meningitis.
  • A range of meningococcal vaccines are available domestically in China.
  • There is an ongoing need to monitor vaccine efficacy and duration of immunity.

Conclusions:

  • Continued national surveillance is essential for effective meningococcal disease control.
  • Monitoring the immune efficacy and persistence of existing vaccines is necessary.
  • Development of serogroup B meningococcal vaccines requires increased investment and focus.